The ACC Young Scholars Program is designed for high school and undergraduate students who are interested in a career in cardiology, science, or health care. Our goal is to provide an opportunity for ...

The U.S. Food and Drug Administration (FDA) announced on Jan. 13 that Philips is correcting the Monitoring Service Application used with Mobile Cardiac Telemetry Monitoring as some electrocardiogram ...

The SUMMIT trial compared the safety and efficacy of tirzepatide among patients with heart failure with preserved ejection fraction (HFpEF) and obesity. Results from the trial concluded that treatment ...

Tell us about you so we can serve you better. ACC requests information from its members on gender, ethnicity and race as part of the College's aim to develop a more diverse and inclusive ...

Check out a new slide lecture, "Cardiac Amyloidosis Foundations," as part of ACC's free online course, Cardiac Amyloidosis: Accelerating Diagnosis and Treatment. Learn to identify symptomology of ...

The utility of left atrial appendage occlusion (LAAO) as a therapy for stroke prevention in patients with nonvalvular atrial fibrillation (AFib) is the focus of a State-of-the-Art Review published Jan ...

Whether you are a seasoned attendee or attending your first ACC Annual Scientific Session this year, don't miss the CV Team Section Town Hall, taking place ahead of ACC.25 on Wednesday, March 12 at ...

ACC's CV Team Section is offering travel awards for cardiovascular team members to attend ACC.25, taking place March 29-31, in Chicago, IL. Expenses including airfare, lodging, meals, and ground ...

A new collaboration between JACC and the U.S. Food and Drug Administration (FDA), will give cardiovascular clinicians a voice in shaping priorities for postmarket evidence generation in cardiovascular ...

The U.S. Food and Drug Administration (FDA) has approved the FARAPULSE Pulsed Field Ablation System for isolation of pulmonary veins in the treatment of drug-refractory, recurrent, symptomatic, ...

The U.S. Food and Drug Administration (FDA) has issued a safety communication noting the potential need for early device replacement of Boston Scientific Corporation Accolade pacemaker devices.

The Centers for Medicare and Medicaid Services (CMS) created two new G codes in the 2025 Medicare Physician Fee Schedule final rule that will provide reimbursement for atherosclerotic cardiovascular ...